loading
Schlusskurs vom Vortag:
$1.54
Offen:
$1.57
24-Stunden-Volumen:
145.61K
Relative Volume:
0.16
Marktkapitalisierung:
$84.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.16M
KGV:
-0.532
EPS:
-2.97
Netto-Cashflow:
$-130.08M
1W Leistung:
-6.47%
1M Leistung:
-27.06%
6M Leistung:
+198.37%
1J Leistung:
+9.66%
1-Tages-Spanne:
Value
$1.54
$1.64
1-Wochen-Bereich:
Value
$1.49
$1.68
52-Wochen-Spanne:
Value
$0.404
$2.27

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
Firmenname
Alx Oncology Holdings Inc
Name
Telefon
650-466-7125
Name
Adresse
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Mitarbeiter
49
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ALXO's Discussions on Twitter

Vergleichen Sie ALXO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
1.58 82.47M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.56 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
641.11 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
430.09 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
824.14 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.19 40.44B 447.02M -1.18B -868.57M -6.1812

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-06 Hochstufung Jefferies Hold → Buy
2024-12-19 Herabstufung Jefferies Buy → Hold
2024-03-08 Herabstufung Stifel Buy → Hold
2023-12-08 Hochstufung Jefferies Hold → Buy
2021-12-22 Herabstufung Jefferies Buy → Hold
2021-09-30 Eingeleitet Stifel Buy
2021-05-05 Fortgesetzt Credit Suisse Outperform
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-06 Eingeleitet UBS Buy
2021-02-10 Eingeleitet H.C. Wainwright Buy
2020-08-11 Eingeleitet Cantor Fitzgerald Overweight
2020-08-11 Eingeleitet Credit Suisse Outperform
2020-08-11 Eingeleitet Jefferies Buy
2020-08-11 Eingeleitet Piper Sandler Overweight
Alle ansehen

Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten

pulisher
05:11 AM

Is ALX Oncology Holdings Inc. stock attractive for hedge fundsSell Signal & Technical Pattern Recognition Alerts - newser.com

05:11 AM
pulisher
04:39 AM

Statistical indicators supporting ALX Oncology Holdings Inc.’s strengthRisk Management & Free High Accuracy Swing Entry Alerts - newser.com

04:39 AM
pulisher
04:35 AM

Can ALX Oncology Holdings Inc. hit a new high this monthJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

04:35 AM
pulisher
02:57 AM

Analyzing recovery setups for ALX Oncology Holdings Inc. investorsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com

02:57 AM
pulisher
02:40 AM

Will ALX Oncology Holdings Inc. continue its uptrend2025 Support & Resistance & Fast Gaining Stock Reports - newser.com

02:40 AM
pulisher
01:13 AM

How to build a dashboard for ALX Oncology Holdings Inc. stockJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com

01:13 AM
pulisher
Nov 02, 2025

Can ALX Oncology Holdings Inc. stock attract ESG capital inflowsIPO Watch & Short-Term Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Key metrics from ALX Oncology Holdings Inc.’s quarterly dataTrade Risk Assessment & Low Risk High Reward Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will ALX Oncology Holdings Inc. stock reach Wall Street targetsJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

ALX Oncology Holdings Inc. (ALXO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 02, 2025
pulisher
Nov 01, 2025

Will ALX Oncology Holdings Inc. outperform the marketWeekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will ALX Oncology Holdings Inc. benefit from macro trendsChart Signals & High Win Rate Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is ALX Oncology Holdings Inc. stock a buy before product launches2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Visual analytics tools that track ALX Oncology Holdings Inc. performanceRecession Risk & AI Optimized Trade Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Volatility Report & Stepwise Swing Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Building trade automation scripts for ALX Oncology Holdings Inc.Trade Entry Report & Consistent Profit Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

ALX Oncology (ALXO) Expected to Announce Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 30, 2025

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

ALX Oncology (NASDAQ: ALXO) to review biomarker data at SITC, report Q3 2025 results - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

ALX Oncology’s ASPEN-09 Study: A Promising Update for Cancer Treatment - MSN

Oct 30, 2025

Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Alx Oncology Holdings Inc-Aktie (ALXO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Lettmann Jason
CHIEF EXECUTIVE OFFICER
Sep 16 '25
Buy
1.07
21,070
22,461
233,958
Shantharam Harish
Chief Financial Officer
Aug 18 '25
Buy
0.78
75,000
58,402
75,000
Pinto Shelly
SVP, FINANCE AND CAO
Aug 15 '25
Sale
0.64
611
391
89,198
Lettmann Jason
CHIEF EXECUTIVE OFFICER
Aug 15 '25
Sale
0.64
2,382
1,525
212,888
Pinto Shelly
SVP, FINANCE AND CAO
Jul 07 '25
Sale
0.45
2,011
905
86,809
Pinto Shelly
SVP, FINANCE AND CAO
Jun 30 '25
Sale
0.43
1,532
659
88,820
Pinto Shelly
SVP, FINANCE AND CAO
Feb 19 '25
Sale
1.15
550
633
87,352
Pons Jaume
PRESIDENT & CSO
Feb 19 '25
Sale
1.15
1,326
1,525
579,388
Lettmann Jason
CHIEF EXECUTIVE OFFICER
Feb 19 '25
Sale
1.15
2,159
2,483
170,270
Pinto Shelly
Interim CFO
Jan 06 '25
Sale
1.80
2,221
3,998
87,902
$37.61
price up icon 0.19%
$28.67
price up icon 0.19%
$101.15
price up icon 8.13%
$104.06
price up icon 0.02%
biotechnology ONC
$311.91
price up icon 0.46%
$186.51
price down icon 1.82%
Kapitalisierung:     |  Volumen (24h):